NIH Triage

The Scientist, Oct. 17, 1994, page 13) concerning my commentary "Triage At NIH: A Smoke Screen Concealing The Real Problems Facing American Science" (The Scientist, Sept. 5, 1994, page 13) contains some interesting news, but also some unsubstantiated statements. I was glad to learn that the National Institute of Mental Health (NIMH) has changed the triage procedures regarding communication with the applicants, who now will receive th

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It is good to know that the plans were changed, and that the applicants will receive the reviewers' full comments. The bad news is that the change will impose an even higher burden on the study-section members, who now must write their reviews in an objective editorial style, suitable for consumption by deeply disappointed applicants. In the good old days, reviewers who do not write well, like me, relied on the editorial abilities and good judgment of the scientific-review administrators. It is obvious that to write the critiques in final form will require more time and effort, no matter what Stamper says. However, this problem has been neglected, perhaps because reviewers are not paid for their writing time. Despite the reviewers' increase in work, applicants whose proposals are deemed NC will not receive a summary of the IRG discussions. This can hardly be considered an advantage for the applicants, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jose Musacchio

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide